Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024

BUY
$5.97 - $10.36 $51,724 - $89,759
8,664 Added 32.3%
35,484 $348,000
Q2 2023

Jul 18, 2023

BUY
$9.97 - $14.05 $66,489 - $93,699
6,669 Added 33.1%
26,820 $356,000
Q1 2023

Apr 20, 2023

BUY
$7.94 - $12.02 $15,880 - $24,040
2,000 Added 11.02%
20,151 $233,000
Q4 2022

Jan 10, 2023

SELL
$5.67 - $11.2 $11,340 - $22,400
-2,000 Reduced 9.93%
18,151 $0
Q3 2022

Oct 13, 2022

BUY
$3.93 - $8.57 $7,860 - $17,140
2,000 Added 11.02%
20,151 $117,000
Q1 2022

Apr 14, 2022

BUY
$8.43 - $20.9 $153,012 - $379,355
18,151 New
18,151 $165,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Mc Guire Investment Group, LLC Portfolio

Follow Mc Guire Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Guire Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Guire Investment Group, LLC with notifications on news.